Jefferies Adjusts Price Target on Welltower to $261 From $270, Keeps Buy Rating
Source: Moomoo • Published: 2026-08-12
BearishJefferies has adjusted its price target for Welltower (NYSE: WELL) to $261, down from the previous $270, while maintaining a Buy rating on the stock. This revision reflects a change in the firm's valuation outlook for the real estate investment trust specializing in healthcare properties.
View original source →Welltower Stock: Analyst Estimates & Ratings
Source: Yahoo • Published: 2026-08-11
NeutralWelltower has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.
View original source →E. Ohman J or Asset Management AB Sells 5,830 Shares of Welltower Inc. $WELL
Source: MarketBeat • Published: 2026-08-11
BullishE. Ohman J or Asset Management AB reduced its stake in Welltower Inc. (NYSE:WELL) by 19.8% in the second quarter, selling 5,830 shares and retaining 23,555 shares valued at $5.35 million. Despite this, other institutional investors have increased their positions in the real estate investment trust. Analysts have issued a "Moderate Buy" consensus rating for Welltower, with an average price target of $246.11, and the company recently declared a quarterly dividend increase to $0.85 per share.